Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Printer Friendly Page Follow BioNews on Twitter BioNews RSS feed

 

Login



Futures in Reproduction

CONTENTS

Issue 256 (05 May 2004)

COMMENT
NEWS DIGEST
REVIEWS


You are currently viewing the HTML Alert version of the BioNews email newsletter.

Click here to view the HTML Full Text version, or here to view the Plain Text version.

Welcome to BioNews by email, the free weekly news digest of the top stories in assisted conception, genetics, embryo/stem cell research and related areas, published by the Progress Educational Trust. Sent to registered subscribers each week, BioNews by email is aimed at informing debate in these areas by providing balanced and timely summaries of the week's news and developments alongside comment, reviews and recommendations of selected topical conferences, events and more. It also contains job advertisements from the relevant sectors.

Visit the BioNews website at www.bionews.org.uk where you can subscribe for free to receive BioNews by email in one of three formats, plus view more news, comment, reviews and job advertisements and search the full archive.

Comment

Genetics, scientists and the media
05 May 2004 - by Juliet Tizzard
In BioNews this week we report on a Canadian study which suggests that genetics is not overhyped by the media. For many people involved in genetic research or clinical services, the findings may come as a surprise. Feeling rather under siege from the media, they sometimes assume that coverage is...[Read More]

News Digest

Gene therapy hope for Alzheimer's
29 April 2004 - by BioNews
Injecting genetically modified skin cells into the brain appears to slow the effects of Alzheimer's disease, and could lead to a new treatment for this disorder, US researchers say. Scientists at the University of California, San Diego (UCSD) presented the results of a small, preliminary study at the American Academy...[Read More]

Heartening news for stem cell treatments
29 April 2004 - by BioNews
Patients with heart failure could one day be treated with injections of their own stem cells, according to new US trials that provide the 'first convincing evidence' that such an approach might work. Previous studies have produced conflicting results, and some researchers have questioned whether stem cell therapies for failing...[Read More]

Congress asks Bush for change of heart on stem cells
29 April 2004 - by BioNews
A letter signed by 206 cross-party members of the US House of Representatives has been sent to President Bush, asking him to change his policy on embryonic stem (ES) cell research. On 9 August 2001, the President issued an executive order limiting the availability of federal funds for ES cell...[Read More]

Male fertility also damaged by chlamydia infection
30 April 2004 - by BioNews
Chlamydia infection in men is linked to infertility, say Swedish researchers in the May issue of the journal Human Reproduction, who have found that infection in men appears to lessen the chance of their partners becoming pregnant. In a study of 244 couples attending a fertility clinic, the researchers, from...[Read More]

Brain cells and teeth from stem cells
30 April 2004 - by BioNews
Adult bone marrow stem cells can turn into brain cells, a finding that could lead to new treatments for brain disorders such as Parkinson's disease, US researchers say. The new study, published in the Lancet, provides more evidence that bone marrow can produce other types of tissue, as well as...[Read More]

No evidence of media 'genohype'
04 May 2004 - by BioNews
Despite fears of widespread 'genohype', most newspaper reports about developments in genetics are accurate, a new Canadian study reveals. Articles about genetics in broadsheet newspapers reflect the claims made in scientific papers, conclude authors Tania Bubela and Timothy Caulfield, of the University of Alberta in Edmonton, Canada. However, they did...[Read More]

Personalised cancer treatments show promise
04 May 2004 - by BioNews
Targeted cancer treatments, based on genetic profiling results, could soon become a reality. A team lead by researchers at the Dana-Farber Cancer Institute, in the US, has found that only lung tumours with a particular gene mutation are likely to respond to treatment with the drug gefitinib. The work is...[Read More]

Reviews

 

BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read


The Progress Educational Trust has been shortlisted for the Charity Times Awards 2011

Good Fundraising Code


Advertise your products and services HERE - click for further details